Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 540

1.

Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614).

Yin J, LaPlant B, Uy GL, Marcucci G, Blum W, Larson RA, Stone RM, Mandrekar SJ.

Blood Adv. 2019 Jun 11;3(11):1714-1721. doi: 10.1182/bloodadvances.2018026112.

2.

Effect of Mixing Duration on Biogas Production and Methanogen Distribution in an Anaerobic Digester.

Wang H, Larson RA, Borchardt M, Spencer S.

Environ Technol. 2019 Jun 4:1-19. doi: 10.1080/09593330.2019.1621951. [Epub ahead of print]

PMID:
31159681
3.

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.

Ustun C, Le-Rademacher J, Wang HL, Othus M, Sun Z, Major B, Zhang MJ, Storrick E, Lafky JM, Chow S, Mrózek K, Attar EC, Nand S, Bloomfield CD, Cripe LD, Tallman MS, Appelbaum F, Larson RA, Marcucci G, Roboz GJ, Uy GL, Stone RM, Jatoi A, Shea TC, de Lima M, Foran JM, Sandmaier BM, Litzow MR, Erba HP, Hurria A, Weisdorf DJ, Artz AS.

Leukemia. 2019 May 9. doi: 10.1038/s41375-019-0477-x. [Epub ahead of print]

PMID:
31073153
4.

Widespread Deposition in a Coastal Bay Following Three Major 2017 Hurricanes (Irma, Jose, and Maria).

Browning TN, Sawyer DE, Brooks GR, Larson RA, Ramos-Scharrón CE, Canals-Silander M.

Sci Rep. 2019 May 8;9(1):7101. doi: 10.1038/s41598-019-43062-4.

5.

The Application of Virtual Reality in Patient Education.

Pandrangi VC, Gaston B, Appelbaum NP, Albuquerque FC Jr, Levy MM, Larson RA.

Ann Vasc Surg. 2019 Apr 19. pii: S0890-5096(19)30247-X. doi: 10.1016/j.avsg.2019.01.015. [Epub ahead of print]

PMID:
31009725
6.

Nitrate sorption to biochar following chemical oxidation.

Sanford JR, Larson RA, Runge T.

Sci Total Environ. 2019 Jun 15;669:938-947. doi: 10.1016/j.scitotenv.2019.03.061. Epub 2019 Mar 6.

PMID:
30970460
7.

Patients' perspectives on the definition of cure in chronic myeloid leukemia.

Flynn KE, Mauro MJ, George G, Hinman A, Baim A, Kota V, Larson RA, Lipton JH, Thompson JE, Wadleigh M, Atallah E.

Leuk Res. 2019 May;80:40-42. doi: 10.1016/j.leukres.2019.03.007. Epub 2019 Mar 28. No abstract available.

PMID:
30955853
8.

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.

Stock W, Luger SM, Advani AS, Yin J, Harvey RC, Mullighan CG, Willman CL, Fulton N, Laumann KM, Malnassy G, Paietta E, Parker E, Geyer S, Mrózek K, Bloomfield CD, Sanford B, Marcucci G, Liedtke M, Claxton DF, Foster MC, Bogart JA, Grecula JC, Appelbaum FR, Erba H, Litzow MR, Tallman MS, Stone RM, Larson RA.

Blood. 2019 Apr 4;133(14):1548-1559. doi: 10.1182/blood-2018-10-881961. Epub 2019 Jan 18.

PMID:
30658992
9.

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant.

Fan Y, Artz AS, van Besien K, Stock W, Larson RA, Odenike O, Godley LA, Kline J, Cunningham JM, LaBelle JL, Bishop MR, Liu H.

Exp Hematol Oncol. 2019 Jan 3;8:1. doi: 10.1186/s40164-018-0125-6. eCollection 2019.

10.

Imatinib is still recommended for frontline therapy for CML.

Hantel A, Larson RA.

Blood Adv. 2018 Dec 26;2(24):3648-3652. doi: 10.1182/bloodadvances.2018018614. No abstract available.

11.

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance).

Roboz GJ, Mandrekar SJ, Desai P, Laumann K, Walker AR, Wang ES, Kolitz JE, Powell BL, Attar EC, Stock W, Bloomfield CD, Kohlschmidt J, Mrózek K, Hassane DC, Garraway L, Jané-Valbuena J, Baltay M, Tracy A, Marcucci G, Stone RM, Larson RA.

Blood Adv. 2018 Dec 26;2(24):3608-3617. doi: 10.1182/bloodadvances.2018023689.

12.

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.

Woyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JC.

N Engl J Med. 2018 Dec 27;379(26):2517-2528. doi: 10.1056/NEJMoa1812836. Epub 2018 Dec 1.

PMID:
30501481
13.

Treatment of Acute Promyelocytic Leukemia in Adults.

Osman AEG, Anderson J, Churpek JE, Christ TN, Curran E, Godley LA, Liu H, Thirman MJ, Odenike T, Stock W, Larson RA.

J Oncol Pract. 2018 Nov;14(11):649-657. doi: 10.1200/JOP.18.00328.

PMID:
30423270
14.

Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance).

Kutny MA, Geyer S, Laumann KM, Gregory J, Willman CL, Stock W, Larson RA, Powell BL, Feusner JH.

Pediatr Blood Cancer. 2019 Mar;66(3):e27542. doi: 10.1002/pbc.27542. Epub 2018 Nov 4.

PMID:
30393935
15.

Characterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantation.

D'Angelo CR, Novitsky B, Mee Lee S, Godley LA, Kline J, Larson RA, Liu H, Odenike O, Stock W, Bishop MR, Artz AS.

Leuk Lymphoma. 2019 Mar;60(3):629-638. doi: 10.1080/10428194.2018.1493728. Epub 2018 Aug 2.

PMID:
30070150
16.

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).

Byrd JC, Ruppert AS, Heerema NA, Halvorson AE, Hoke E, Smith MR, Godwin JE, Couban S, Fehniger TA, Thirman MJ, Tallman MS, Appelbaum FR, Stone RM, Robinson S, Chang JE, Mandrekar SJ, Larson RA.

Blood Adv. 2018 Jul 24;2(14):1705-1718. doi: 10.1182/bloodadvances.2017015396.

17.

Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia.

Stein AS, Larson RA, Schuh AC, Stevenson W, Lech-Maranda E, Tran Q, Zimmerman Z, Kormany W, Topp MS.

Blood Adv. 2018 Jul 10;2(13):1522-1531. doi: 10.1182/bloodadvances.2018019034.

18.

Use and impact of patient relationship modifiers on cost measurement.

Larson RA, Johnson B, Woo K, Rathbun JA, Copeland TP.

J Vasc Surg. 2018 Jul;68(1):307. doi: 10.1016/j.jvs.2018.05.030. No abstract available.

PMID:
29937035
19.

Author Correction: RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.

Cheng JX, Chen L, Li Y, Cloe A, Yue M, Wei J, Watanabe KA, Shammo JM, Anastasi J, Shen QJ, Larson RA, He C, Le Beau MM, Vardiman JW.

Nat Commun. 2018 Jun 6;9(1):2286. doi: 10.1038/s41467-018-04518-9.

20.

Measurement of cations, anions, and acetate in serum, urine, cerebrospinal fluid, and tissue by ion chromatography.

Chapp AD, Schum S, Behnke JE, Hahka T, Huber MJ, Jiang E, Larson RA, Shan Z, Chen QH.

Physiol Rep. 2018 Apr;6(7):e13666. doi: 10.14814/phy2.13666.

21.

Fate of Manure-Borne Pathogens during Anaerobic Digestion and Solids Separation.

Burch TR, Spencer SK, Borchardt SS, Larson RA, Borchardt MA.

J Environ Qual. 2018 Mar;47(1):336-344. doi: 10.2134/jeq2017.07.0285.

PMID:
29634802
22.

Increased cardiac sympathetic activity: Cause or compensation in vasovagal syncope?

Larson RA, Chapleau MW.

Clin Auton Res. 2018 Jun;28(3):265-266. doi: 10.1007/s10286-018-0524-0. Epub 2018 Apr 3. No abstract available.

23.

Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.

Atallah E, Schiffer CA, Weinfurt KP, Zhang MJ, Radich JP, Oehler VG, Pinilla-Ibarz J, Deininger MWN, Lin L, Larson RA, Mauro MJ, Moore JO, Ritchie EK, Shah NP, Silver RT, Wadleigh M, Cortes J, Thompson J, Guhl J, Horowitz MM, Flynn KE.

BMC Cancer. 2018 Apr 2;18(1):359. doi: 10.1186/s12885-018-4273-1.

24.

RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.

Cheng JX, Chen L, Li Y, Cloe A, Yue M, Wei J, Watanabe KA, Shammo JM, Anastasi J, Shen QJ, Larson RA, He C, Le Beau MM, Vardiman JW.

Nat Commun. 2018 Mar 21;9(1):1163. doi: 10.1038/s41467-018-03513-4. Erratum in: Nat Commun. 2018 Jun 6;9(1):2286.

25.

Expression of Proinflammatory Cytokines Is Upregulated in the Hypothalamic Paraventricular Nucleus of Dahl Salt-Sensitive Hypertensive Rats.

Jiang E, Chapp AD, Fan Y, Larson RA, Hahka T, Huber MJ, Yan J, Chen QH, Shan Z.

Front Physiol. 2018 Feb 22;9:104. doi: 10.3389/fphys.2018.00104. eCollection 2018.

26.

Tracing the incorporation of carbon into benthic foraminiferal calcite following the Deepwater Horizon event.

Schwing PT, Chanton JP, Romero IC, Hollander DJ, Goddard EA, Brooks GR, Larson RA.

Environ Pollut. 2018 Jun;237:424-429. doi: 10.1016/j.envpol.2018.02.066. Epub 2018 Mar 15.

PMID:
29502005
27.

Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis.

Stone RM, Manley PW, Larson RA, Capdeville R.

Blood Adv. 2018 Feb 27;2(4):444-453. doi: 10.1182/bloodadvances.2017011080. Review. Erratum in: Blood Adv. 2018 Apr 10;2(7):787.

28.

WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.

Liu H, Zha Y, Choudhury N, Malnassy G, Fulton N, Green M, Park JH, Nakamura Y, Larson RA, Salazar AM, Odenike O, Gajewski TF, Stock W.

Exp Hematol Oncol. 2018 Jan 11;7:1. doi: 10.1186/s40164-018-0093-x. eCollection 2018.

29.

A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.

Wang AY, Weiner H, Green M, Chang H, Fulton N, Larson RA, Odenike O, Artz AS, Bishop MR, Godley LA, Thirman MJ, Kosuri S, Churpek JE, Curran E, Pettit K, Stock W, Liu H.

J Hematol Oncol. 2018 Jan 5;11(1):4. doi: 10.1186/s13045-017-0550-8.

30.

Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.

Tsai SB, Rhodes J, Liu H, Shore T, Bishop M, Cushing MM, Gergis U, Godley L, Kline J, Larson RA, Mayer S, Odenike O, Stock W, Wickrema A, van Besien K, Artz AS.

Biol Blood Marrow Transplant. 2018 May;24(5):997-1004. doi: 10.1016/j.bbmt.2017.12.794. Epub 2017 Dec 27.

31.

Pepsi® or Coke®? Influence of acid on dasatinib absorption.

Knoebel RW, Larson RA.

J Oncol Pharm Pract. 2018 Mar;24(2):156-158. doi: 10.1177/1078155217692152. Epub 2017 Feb 28. Review.

PMID:
29284366
32.

Tips for participating in the Quality Payment Program in 2018 and beyond.

Simons JP, Larson RA, Woo K, Rathbun JA, Johnson BL.

J Vasc Surg. 2017 Dec;66(6):1909. doi: 10.1016/j.jvs.2017.09.005. No abstract available.

PMID:
29169547
33.

Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.

Stone RM, Larson RA, Döhner H.

N Engl J Med. 2017 Nov 9;377(19):1903. doi: 10.1056/NEJMc1711340. No abstract available.

PMID:
29117486
34.

Proposed Quality Payment Program changes for 2018.

Larson RA, Simons JP, Johnson BL, Rathbun JA, Woo K.

J Vasc Surg. 2017 Nov;66(5):1611. doi: 10.1016/j.jvs.2017.08.024. No abstract available.

PMID:
29061275
35.

A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001.

Uy GL, Mandrekar SJ, Laumann K, Marcucci G, Zhao W, Levis MJ, Klepin HD, Baer MR, Powell BL, Westervelt P, DeAngelo DJ, Stock W, Sanford B, Blum WG, Bloomfield CD, Stone RM, Larson RA.

Blood Adv. 2017 Jan 24;1(5):331-340. doi: 10.1182/bloodadvances.2016003053.

36.

Quantitative Microbial Risk Assessment for Spray Irrigation of Dairy Manure Based on an Empirical Fate and Transport Model.

Burch TR, Spencer SK, Stokdyk JP, Kieke BA Jr, Larson RA, Firnstahl AD, Rule AM, Borchardt MA.

Environ Health Perspect. 2017 Aug 16;125(8):087009. doi: 10.1289/EHP283.

37.

Notes from the Field: Death of a Farm Worker After Exposure to Manure Gas in an Open Air Environment - Wisconsin, August 2016.

Shutske JM, Larson RA, Schaefer DM, Binversie LY, Rifleman S, Skjolaas C.

MMWR Morb Mortal Wkly Rep. 2017 Aug 18;66(32):861-862. doi: 10.15585/mmwr.mm6632a6. No abstract available.

38.

Increased activity of the orexin system in the paraventricular nucleus contributes to salt-sensitive hypertension.

Huber MJ, Fan Y, Jiang E, Zhu F, Larson RA, Yan J, Li N, Chen QH, Shan Z.

Am J Physiol Heart Circ Physiol. 2017 Dec 1;313(6):H1075-H1086. doi: 10.1152/ajpheart.00822.2016. Epub 2017 Jun 30.

39.

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.

Perl AE, Altman JK, Cortes J, Smith C, Litzow M, Baer MR, Claxton D, Erba HP, Gill S, Goldberg S, Jurcic JG, Larson RA, Liu C, Ritchie E, Schiller G, Spira AI, Strickland SA, Tibes R, Ustun C, Wang ES, Stuart R, Röllig C, Neubauer A, Martinelli G, Bahceci E, Levis M.

Lancet Oncol. 2017 Aug;18(8):1061-1075. doi: 10.1016/S1470-2045(17)30416-3. Epub 2017 Jun 20. Erratum in: Lancet Oncol. 2017 Dec;18(12 ):e711. Lancet Oncol. 2018 Jul;19(7):e335. Erratum in: Lancet Oncol. 2019 Jun;20(6):e293.

40.

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

Stone RM, Mandrekar SJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, Thiede C, Prior TW, Döhner K, Marcucci G, Lo-Coco F, Klisovic RB, Wei A, Sierra J, Sanz MA, Brandwein JM, de Witte T, Niederwieser D, Appelbaum FR, Medeiros BC, Tallman MS, Krauter J, Schlenk RF, Ganser A, Serve H, Ehninger G, Amadori S, Larson RA, Döhner H.

N Engl J Med. 2017 Aug 3;377(5):454-464. doi: 10.1056/NEJMoa1614359. Epub 2017 Jun 23.

41.

Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy.

Fenaux P, Muus P, Kantarjian H, Lyons RM, Larson RA, Sekeres MA, Becker PS, Orejudos A, Franklin J.

Br J Haematol. 2017 Sep;178(6):906-913. doi: 10.1111/bjh.14792. Epub 2017 Jun 14.

42.

Managing CNS disease in adults with acute lymphoblastic leukemia.

Larson RA.

Leuk Lymphoma. 2018 Jan;59(1):3-13. doi: 10.1080/10428194.2017.1326597. Epub 2017 May 23. Review.

PMID:
28535095
43.

Constraining the Spatial Extent of Marine Oil Snow Sedimentation and Flocculent Accumulation Following the Deepwater Horizon Event Using an Excess 210Pb Flux Approach.

Schwing PT, Brooks GR, Larson RA, Holmes CW, O'Malley BJ, Hollander DJ.

Environ Sci Technol. 2017 Jun 6;51(11):5962-5968. doi: 10.1021/acs.est.7b00450. Epub 2017 May 26.

PMID:
28502163
44.

High Salt Intake Augments Excitability of PVN Neurons in Rats: Role of the Endoplasmic Reticulum Ca2+ Store.

Larson RA, Chapp AD, Gui L, Huber MJ, Cheng ZJ, Shan Z, Chen QH.

Front Neurosci. 2017 Apr 6;11:182. doi: 10.3389/fnins.2017.00182. eCollection 2017.

45.

The impact of biogas and fuelwood use on institutional kitchen air quality in Kampala, Uganda.

McCord AI, Stefanos SA, Tumwesige V, Lsoto D, Meding AH, Adong A, Schauer JJ, Larson RA.

Indoor Air. 2017 Nov;27(6):1067-1081. doi: 10.1111/ina.12390. Epub 2017 Jul 11.

PMID:
28423205
46.

Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.

Khan N, Hantel A, Knoebel RW, Artz A, Larson RA, Godley LA, Thirman MJ, Liu H, Churpek JE, King D, Odenike O, Stock W.

Leuk Lymphoma. 2017 Sep;58(9):1-7. doi: 10.1080/10428194.2017.1289524. Epub 2017 Feb 20.

PMID:
28278716
47.

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.

Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O'Brien SG, Druker BJ; IRIS Investigators.

N Engl J Med. 2017 Mar 9;376(10):917-927. doi: 10.1056/NEJMoa1609324.

48.

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.

Mantha S, Goldman DA, Devlin SM, Lee JW, Zannino D, Collins M, Douer D, Iland HJ, Litzow MR, Stein EM, Appelbaum FR, Larson RA, Stone R, Powell BL, Geyer S, Laumann K, Rowe JM, Erba H, Coutre S, Othus M, Park JH, Wiernik PH, Tallman MS.

Blood. 2017 Mar 30;129(13):1763-1767. doi: 10.1182/blood-2016-10-747170. Epub 2017 Jan 12.

49.

FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase.

Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, Huang H, Nachtergaele S, Dong L, Hu C, Qin X, Tang L, Wang Y, Hong GM, Huang H, Wang X, Chen P, Gurbuxani S, Arnovitz S, Li Y, Li S, Strong J, Neilly MB, Larson RA, Jiang X, Zhang P, Jin J, He C, Chen J.

Cancer Cell. 2017 Jan 9;31(1):127-141. doi: 10.1016/j.ccell.2016.11.017. Epub 2016 Dec 22.

50.

Evaluation of Phosphorus Filter Media for an Inline Subsurface Drainage Treatment System.

Sanford JR, Larson RA.

J Environ Qual. 2016 Nov;45(6):1919-1925. doi: 10.2134/jeq2016.01.0038.

PMID:
27898781

Supplemental Content

Loading ...
Support Center